The mitogen-activated protein kinase p38 is necesssary for interleukin 1beta-induced monocyte chemoattractant protein

B H Rovin1, W A Wilmer, M Danne

  • 1Department of Medicine, Division of Nephrology, The Ohio State University, Columbus, OH, USA.

Cytokine
|March 25, 1999
PubMed

Insights

p38 kinase activation is essential for interleukin 1beta (IL-1beta) to induce monocyte chemoattractant protein-1 (MCP-1) expression in human mesangial cells. ERK2 activation does not play a role in this IL-1beta-mediated gene activation.

Area of Science:

  • Cellular and Molecular Biology
  • Immunology
  • Signal Transduction

Background:

  • Mitogen-activated protein (MAP) kinases are implicated in cytokine-induced gene expression.
  • Interleukin 1beta (IL-1beta) is a key inflammatory cytokine.
  • Chemokines like MCP-1 play crucial roles in immune responses.

Purpose of the Study:

  • To investigate the roles of p38 kinase and ERK2 in IL-1beta-induced MCP-1 expression in human mesangial cells.
  • To determine the specific signaling pathways mediating IL-1beta's effects on MCP-1.

Main Methods:

  • Treatment of human mesangial cells with IL-1beta.
  • Assessing p38 and ERK2 activation via phosphorylation and kinase activity assays.
  • Utilizing selective inhibitors SB 203580 (for p38) and PD 098059 (for MEK1).
  • Measuring MCP-1 mRNA and protein levels.
  • Evaluating NF-kappaB activation (nuclear translocation and DNA binding).

Main Results:

  • IL-1beta treatment significantly increased p38 kinase phosphorylation and activity.
  • Inhibition of p38 kinase with SB 203580 reduced IL-1beta-induced MCP-1 mRNA and protein levels.
  • SB 203580 did not affect MCP-1 mRNA stability or IL-1beta-induced NF-kappaB activation.
  • Inhibition of ERK activation with PD 098059 had no impact on IL-1beta-induced MCP-1 expression or NF-kappaB activation.

Conclusions:

  • p38 kinase is a necessary mediator for IL-1beta-induced MCP-1 expression in human mesangial cells.
  • p38 kinase acts downstream of NF-kappaB activation in this pathway.
  • ERK2 does not mediate IL-1beta-induced MCP-1 gene expression in these cells.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...